Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy

Human Gene Therapy

Volumn 10, Issue 5, 1999, Pages 733-740

  Long, Zhifeng ^a   Lu, Patrick ^a   Grooms, Tracey ^a   Mychkovsky, Ihor ^a   Westley, Tonya ^a   Fitzgerald, Teresa ^a   Sharma Chibber, Sona ^a   Shand, Nicholas ^a   McGarrity, Gerard ^a   Otto, Edward ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VECTOR;

ARTICLE; AUTOPSY; BRAIN TISSUE; BRAIN TUMOR; CONTROLLED STUDY; FEMALE; GENE THERAPY; GONAD; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RETROVIRUS; TUMOR BIOPSY;

AUTOPSY; BIOPSY; BRAIN; DNA; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; LYMPHOCYTES; MALE; MODELS, GENETIC; POLYMERASE CHAIN REACTION; RETROVIRIDAE; TISSUE DISTRIBUTION;

DNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0033586306     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018490     Document Type: Article

References (23)

1. ANONYMOUS, (1997). Human gene marker/therapy clinical protocols. Hum. Gene Ther. 8, 2301-2338.
2. CAIRNS, J. (1975). Mutation selection and the natural history of cancer. Nature (London) 255, 197-200.
3. CHONG, H., STARKEY, W., and VILE, R.G. (1998). A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J. Virol. 72, 2663-2670.
4. DONAHUE, R.E., KESSLER, S.W., BODINE, D., MCDONAGH, K., BYME, E., RAFFIELD, M., MOEN, R., BACHER, J., ZSEBO, K.M., and NIENHUIS, A.W. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176, 1125-1135.
5. FRANKEL, W., POTTER, T.A., ROSENBERG, N., LENZ, J., and RAJAN, T.V. (1985). Retroviral insertional mutagenesis of a target allele in a heterozygous murine cell line. Proc. Natl. Acad. Sci. U.S.A. 82, 6600-6604.
6. GROSOVSKY, A.J., SKANDALIS, A., HASEGAWA, L., and WALTER, B.N. (1993). Insertional inactivation of the tk locus in a human B lymphoblastoid cell line by a retroviral shuttle vector. Mutat. Res. 289, 297-308.
7. LOCKEY, C., OTTO, E., and LONG, Z. (1998). Real time fluorescence detection of a single DNA molecule. BioTechniques 24, 744-746.
8. LONG, Z., LI, L.-P., GROOMS, T., LOCKEY, C., NADER, K., MYCHKOWVSKY, I., MUELLER, S., BURIMSKI, I., RYAN, P., KIKUCHI, G., ENNIST, D., MARCUS, S., OTTO, E., and McGARRITY, G. (1998). Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells. Hum. Gene Ther. 9, 1165-1172.
9. LYONS, R.M., FORRY-SCHAUDIES, S., OTTO, E., WEY, C., PATIL-KOOTA, V., KALOSS, M., MCGARRITY, G., and CHIANG, Y.L. (1995). An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. Can. Gene Ther. 2, 273-280.
10. MARTINEAU, D., KLUMP, W.M., MCCORMACK, J.E., DEPOLO, N.J., KAMANTIGUE, E., PETROWSKI, M., HANLON, J., JOLLY, D.J., MENTO, S.J., and SAJJADI, N. (1997). Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus. Hum. Gene Ther. 8, 1231-1241.
11. MCCORMACK, J.E., MARTINEAU, D., DePOLO, N., MAIFERT, S., AKBARIAN, L., TOWNSEND, K., LEE, W., IRWIN, M., SAJJADI, N., JOLLY, D., and WARNER, J. (1997). Anti-vector immunoglobulin induced by retroviral vectors. Hum. Gene Ther. 8, 1263-1273.
12. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 6, 2895-2902.
13. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
14. MILLER, A.D., BONHAM, L., ALFANO, J., KIEM, H.P., REYNOLDS, T., and WOLGAMOT, G. (1996). A novel murine retrovirus identified during testing for helper virus in human gene transfer trials. J. Virol. 70, 1804-1809.
15. NOWELL, P.C. (1976). The clonal evolution of tumor cell populations. Science 194, 23-28.
16. OTTO, E., JONES-TROWER, A., VANIN, E.F., STAMBAUGH, K., MUELLER, S.N., ANDERSON, W.F., and MCGARRITY, G.J. (1994). Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 5, 567-575.
17. RAM, Z., CULVER, K., OSHIRO, E.M., VIOLA, J.J., DEVROOM, H.L., OTTO, E., LONG, Z., CHIANG, Y., MCGARRITY, G.J., MUUL, L.M., KATZ, D., BLAESE, R.M., and OLDFIELD, E.H. (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producer cells. Nature Med. 3, 1354-1361.
18. RAC (Recombinant DNA Advisory Committee). (1998). Minutes of Meeting, Attachments II, III, and IV, December 15-16, 1997. Hum. Gene Ther. 9, 1643-1695.
19. VANIN, E.F., KALOSS, M., BROSCIUS, C., and NIENHUIS, A.W. (1994). Characterization of a replication-competent retrovirus from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68, 4241-4250.
20. VAN ZEIJL, M., JOHANN, S.V., CLOSS, E., CUNNINGHAM, J., EDDY, R., SHOWS, T.B., and O'HARA, B. (1994). A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. U.S.A. 91, 1168-1172.
21. VARMUS, H.E., QUINTRELL, N., and ORTIZ, S. (1981). Retroviruses as mutagens: Insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus. Cell 25, 23-36.
22. VOGELSTEIN, B., and KINZLER, K.W. (1993). The multistep nature of cancer. Trends Genet. 9, 138-141.
23. WILSON, C.A., NG, T.-H., and MILLER, A.E. (1997). Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors. Hum. Gene Ther. 8, 869-874.